/ALPHE.PA
ALPHE.PA Stock - Pherecydes Pharma S.A.
Healthcare|BiotechnologyPAR
$2.00-0.50%
$0.01 (-0.50%) • Jun 23
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.19
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.81
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $2.20
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ALPHE.PA
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.98 – $2.02
TARGET (TP)$2.30
STOP LOSS$1.84
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.99
52W High$4.45
52W Low$1.72
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $3.16M | $2.14M | $1.81M | $2.26M | $92,663 |
| Gross Profit | $-93,178 | $659,036 | $305,783 | $2.26M | $92,663 |
| Gross Margin | -3.0% | 30.8% | 16.9% | 100.0% | 100.0% |
| Operating Income | $-6,690,043 | $-4,373,037 | $-3,475,474 | $-2,691,051 | $-3,211,559 |
| Net Income | $-5,365,466 | $-3,378,526 | $-3,016,193 | $-1,664,538 | $-2,419,726 |
| Net Margin | -170.0% | -157.7% | -166.9% | -73.6% | -2611.3% |
| EPS | $-0.75 | $-0.58 | $-0.53 | $-0.29 | $-0.43 |
Company Overview
Pherecydes Pharma SA develops antibacterial treatments based on the use of bacteriophage viruses or phages. It develops a portfolio of therapeutics, such as anti-Staphylococcus aureusphages for the treatment of bone/joint and diabetic foot ulcer infections; anti-Pseudomonas aeruginosa phages for the treatment of complicated urinary tract infections; and anti-Escherichia coli phages for the treatment of respiratory tract infections. The company was founded in 2006 and is based in Romainville, France.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ALPHE.PABeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$N/A
EPS Surprise History
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2023 | Mar 7, 2023 | — | — | — | — |
Q4 2022 | Nov 16, 2022 | — | — | — | — |
Q3 2022 | Aug 17, 2022 | — | — | — | — |
Q2 2022 | May 16, 2022 | — | — | — | — |
Latest News
Loading news...
Frequently Asked Questions about ALPHE.PA
What is ALPHE.PA's current stock price?
Pherecydes Pharma S.A. (ALPHE.PA) is currently trading at $2.00 per share. The stock has moved -0.50% today.
What is the analyst price target for ALPHE.PA?
No analyst price targets are currently available for this stock.
What sector is Pherecydes Pharma S.A. in?
Pherecydes Pharma S.A. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the PAR exchange.
What is ALPHE.PA's market cap?
Pherecydes Pharma S.A. has a market capitalization of $0.02 billion, making it a small-cap company.
Does ALPHE.PA pay dividends?
No, Pherecydes Pharma S.A. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorALACT.PA
Acticor Biotech SAS
$0.25
Mkt Cap: $0.0B
ALHYG.PA
Hybrigenics S.A.
$0.01
Mkt Cap: $0.0B
ALQGC.PA
Quantum Genomics S.A.
$0.07
Mkt Cap: $0.0B
ALTER.PA
Theradiag S.A.
$1.26
Mkt Cap: $0.0B
ALVET.PA
TheraVet S.A.
$0.08
Mkt Cap: $0.0B
APM.PA
Aptorum Group Limited
$3.21
Mkt Cap: $0.0B
COX.PA
Nicox S.A.
$0.58
Mkt Cap: $0.0B
FALG.PA
Fermentalg S.A.
$0.56
Mkt Cap: $0.0B
LYS.PA
Lysogene S.A.
$0.28
Mkt Cap: $0.0B
PHXM.PA
PHAXIAM Therapeutics S.A.
$0.10
Mkt Cap: $0.0B
Explore stocks similar to ALPHE.PA for comparison